![Hui Jun Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hui Jun Wang
Directeur Général chez
OBI PHARMA, INC.
Profil
Hui Jun Wang is currently Chief Executive Officer at OBI Pharma, Inc. and Chairman at Obigen Pharma, Inc. since 2023.
Formerly, served as Vice President & Global Head-Regulatory Science at Bristol-Myers Squibb (Taiwan) Ltd. Earned a doctorate from the University of Notre Dame.
Postes actifs de Hui Jun Wang
| Sociétés | Poste | Début |
|---|---|---|
| OBIGEN PHARMA INC. | Président | 29/12/2023 |
| OBI PHARMA, INC. | Directeur Général | - |
Anciens postes connus de Hui Jun Wang
| Sociétés | Poste | Fin |
|---|---|---|
Bristol-Myers Squibb (Taiwan) Ltd. | Corporate Officer/Principal | - |
Formation de Hui Jun Wang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb (Taiwan) Ltd. | |
OBI Pharma, Inc.
 OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs | Health Technology |
Obigen Pharma, Inc.
 Obigen Pharma, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures botulinum toxin products | Health Technology |
